Evidium is a San Francisco–based health-tech company building a computational medical knowledge platform that converts medical evidence into precision intelligence. Its technology produces traceable, transparent insights that help clinicians, insurers, risk-bearing organizations, and provider networks understand patient journeys, predict medical and cost trajectories, and improve outcomes. Current products include quality insights for care teams, probabilistic forecasting tools for payers, and advanced clinical and cost modeling solutions that map condition-level care pathways. The company’s precision-first approach allows experts to review the logic behind every prediction, augmenting generative AI with clinically grounded reasoning. With fresh capital, Evidium will deepen its clinical modeling capabilities, extend its product roadmap for life-sciences and health-plan users, and scale commercial operations. It is preparing strategic hires in AI research engineering, clinical science, and business development to meet rising demand across the healthcare ecosystem. Financially, Evidium has just closed a $22 million Series A round to support these growth initiatives.

Total raised

$22M

Funding rounds

1

Latest round

Series A

Latest activity

Dec 2025